Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 4
Submit an article Journal homepage
112
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Complete measurable residual disease response after combination chemotherapy with AML-type and ALL-type regimens in pediatric B/myeloid acute bilineal leukemia

Shoji SaitoDepartment of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan; Correspondence[email protected]
View further author information
,
Chiaki TairaDepartment of Laboratory Medicine, Shinshu University Hospital, Matsumoto, Japan; View further author information
,
Kazuyuki MatsudaDepartment of Laboratory Medicine, Shinshu University Hospital, Matsumoto, Japan; View further author information
,
Ryu YanagisawaDepartment of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan; ;Division of Blood Transfusion, Shinshu University Hospital, Matsumoto, Japan; View further author information
,
Daisuke MoritaDepartment of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan; View further author information
,
Tomonari ShigemuraDepartment of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan; View further author information
,
Kentaro YoshikawaDepartment of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan; View further author information
,
Miyuki TanakaDepartment of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan; View further author information
,
Kazuo SakashitaDepartment of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan; View further author information
,
Saki MukaiDepartment of Laboratory Medicine, Shinshu University Hospital, Matsumoto, Japan; View further author information
,
Shigetaka ShimodairaDivision of Blood Transfusion, Shinshu University Hospital, Matsumoto, Japan; ;Department of Regenerative Medicine, Kanazawa Medical University, Kahoku-Gun, JapanView further author information
,
Kenichi KoikeDepartment of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan; View further author information
&
Yozo NakazawaDepartment of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan; View further author information
 show all
Pages 967-970 | Received 17 Aug 2019, Accepted 19 Nov 2019, Published online: 06 Dec 2019

References

  • Bene MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia. 1995;9(10):1783–1786.
  • Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114(5):937–951.
  • Gerr H, Zimmermann M, Schrappe M, et al. Acute leukaemias of ambiguous lineage in children: characterization, prognosis and therapy recommendations. Br J Haematol. 2010;149(1):84–92.
  • Rubnitz JE, Onciu M, Pounds S, et al. Acute mixed lineage leukemia in children: the experience of St Jude Children's Research Hospital. Blood. 2009;113(21):5083–5089.
  • Weir EG, Ali Ansari-Lari M, Batista DA, et al. Acute bilineal leukemia: a rare disease with poor outcome. Leukemia. 2007;21(11):2264–2270.
  • Hrusak O, de Haas V, Stancikova J, et al. International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia. Blood. 2018;132(3):264–276.
  • Tsukimoto I, Tawa A, Horibe K, et al. Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group. JCO. 2009;27(24):4007–4013.
  • Moricke A, Reiter A, Zimmermann M, et al. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood. 2008;111(9):4477–4489.
  • Zhou J, Goldwasser MA, Li A, et al. Quantitative analysis of minimal residual disease predicts relapse in children with B-lineage acute lymphoblastic leukemia in DFCI ALL Consortium Protocol 95-01. Blood. 2007;110(5):1607–1611.
  • van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17(12):2257–2317.
  • Matsuda K, Nakazawa Y, Yanagisawa R, et al. Detection of T-cell receptor gene rearrangement in children with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis using the BIOMED-2 multiplex polymerase chain reaction combined with GeneScan analysis. Clin Chim Acta. 2011;412(17–18):1554–1558.
  • Taira C, Matsuda K, Saito S, et al. Application of allele-specific quantitative PCR using genomic DNA to monitor minimal residual disease based on mutant gene levels following allogeneic hematopoietic stem cell transplantation in patients with hematological malignancies: comparison of mutant levels with autologous DNA percentage by short tandem repeat-PCR. Clin Chim Acta. 2012;413(3–4):516–519.
  • Mandigers CM, Meijerink JP, Mensink EJ, et al. Lack of correlation between numbers of circulating t(14;18)-positive cells and response to first-line treatment in follicular lymphoma. Blood. 2001;98(4):940–944.
  • Knechtli CJ, Goulden NJ, Hancock JP, et al. Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia. Blood. 1998;92(11):4072–4079.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.